Z Czeglédi

Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn’s disease

Péter L. Lakatos, Z Czeglédi, Tamás Szamosi et al. · World Journal of Gastroenterology · 2009 · 113 citations · Full text

Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohnʼs disease, while smoking decreases the risk of colectomy in ulcerative colitis

Tamás Szamosi, János Banai, Z Czeglédi et al. · European Journal of Gastroenterology & Hepatology · 2010 · 65 citations

Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease

Péter L. Lakatos, Z Czeglédi, Gyula Dávid et al. · Journal of Crohn s and Colitis · 2009 · 48 citations · Full text

Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe - a Hungarian nationwide observational study

Pál Miheller, Péter L. Lakatos, Gábor Horváth et al. · BMC Gastroenterology · 2009 · 37 citations · Full text